Methods of treating cancer using opioid retargeted endpeptidases

Details for Australian Patent Application No. 2010282285 (hide)

Owner Allergan, Inc.

Inventors Jacky, Birgitte P. S.; Garay, Patton E.; Molina, Yanira; Stathakis, Dean G.; Francis, Joseph; Aoki, Kei Roger; Fernandez-Salas, Ester; Steward, Lance E.; Ghanshani, Sanjiv; Hunt, Terrence J.

Agent Davies Collison Cave

Pub. Number AU-A-2010282285

PCT Pub. Number WO2011/020052

Priority 61/233,930 14.08.09 US

Filing date 13 August 2010

Wipo publication date 17 February 2011

International Classifications

C07K 14/33 (2006.01) Peptides having more than 20 amino acids

Event Publications

15 March 2012 PCT application entered the National Phase

  PCT publication WO2011/020052 Priority application(s): WO2011/020052

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010282289-Methods of treating cancer using galanin retargeted endpeptidases

2010282283-Shared server-side macros